Literature DB >> 12226823

Detection of cytomegalovirus DNA in human placenta.

Kaori Kumazaki1, Keiichi Ozono, Takeshi Yahara, Yoshinao Wada, Noriyuki Suehara, Makoto Takeuchi, Masahiro Nakayama.   

Abstract

Although human cytomegalovirus (CMV) is one of the most common causes of viral intrauterine and perinatal infection, its distribution in the placenta is poorly understood. The purpose of this study was to determine the frequency of CMV DNA positivity in placentas, to demonstrate the localization of the viral genome, and to identify the clinical features related to placental CMV. A total of 254 placentas from 231 mothers were investigated, and the maternal serum CMV immunoglobulin antibodies were measured. Specimens from both the placental parenchyma and the placental membrane close to the ruptured site in each placenta were examined for the presence of CMV DNA using dot blot hybridization after PCR amplification. None of 57 placentas from seronegative mothers was positive for CMV DNA. Of 197 placentas from seropositive mothers, 60 (30.5%) had CMV DNA in either the parenchyma or the membrane by dot blot analysis. In situ hybridization was carried out on these 60 placentas, and the localization of the viral genome was established in 19; CMV DNA was localized mostly to the villi, including the mesenchyme and trophoblasts, extravillous trophoblasts, and decidual cells. The mean gestational age at delivery was significantly later in the CMV DNA-positive placentas than in the negative placentas (36.9 +/- 5.1 vs 34.7 +/- 6.2 weeks, P = 0.0059). CMV DNA was detected in only 6 of 33 placentas delivered in the second trimester, and all six were associated with either severe maternal nephritis or severe chorioamnionitis. These results suggest that the CMV genome is common in placentas at later gestational ages and in those of earlier gestational ages with certain maternal complications. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12226823     DOI: 10.1002/jmv.10212

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  6 in total

1.  Human cytomegalovirus is protected from inactivation by reversible binding to villous trophoblasts.

Authors:  Ashley Davey; Lauren Eastman; Priyanka Hansraj; Denise G Hemmings
Journal:  Biol Reprod       Date:  2011-03-02       Impact factor: 4.285

Review 2.  Models of vertical cytomegalovirus (CMV) transmission and pathogenesis.

Authors:  Yiska Weisblum; Amos Panet; Ronit Haimov-Kochman; Dana G Wolf
Journal:  Semin Immunopathol       Date:  2014-10-08       Impact factor: 9.623

3.  Detection of HCMV DNA in placenta, amniotic fluid and fetuses of seropositive women by nested PCR.

Authors:  Mazyar Ziyaeyan; Abdolvahab Alborzi; Amin Abbasian; Mehdi Kalani; Ali Moravej; Jalil Nasiri; Arash Amiri; Niabeddin Hashemi; Firozeh Sefiddashti
Journal:  Eur J Pediatr       Date:  2006-11-03       Impact factor: 3.183

4.  Potential of Anti-CMV Immunoglobulin Cytotect CP® In Vitro and Ex Vivo in a First-Trimester Placenta Model.

Authors:  Perrine Coste Mazeau; Chloé Jacquet; Clotilde Muller; Mathis Courant; Chahrazed El Hamel; Thierry Chianea; Sébastien Hantz; Sophie Alain
Journal:  Microorganisms       Date:  2022-03-23

5.  Single- and double-stranded viral RNA generate distinct cytokine and antiviral responses in human fetal membranes.

Authors:  S L Bakaysa; J A Potter; M Hoang; C S Han; S Guller; E R Norwitz; V M Abrahams
Journal:  Mol Hum Reprod       Date:  2014-04-09       Impact factor: 4.025

6.  Pathogenesis and vertical transmission of a transplacental rat cytomegalovirus.

Authors:  Hwei-San Loh; Mohd-Azmi Mohd-Lila; Sheikh-Omar Abdul-Rahman; Lik-Jun Kiew
Journal:  Virol J       Date:  2006-06-01       Impact factor: 4.099

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.